Vaginal microbiota, genital inflammation, and neoplasia impact immune checkpoint protein profiles in the cervicovaginal microenvironment
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Vaginal microbiota, genital inflammation, and neoplasia impact immune checkpoint protein profiles in the cervicovaginal microenvironment
Authors
Keywords
-
Journal
npj Precision Oncology
Volume 4, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-08-03
DOI
10.1038/s41698-020-0126-x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer statistics, 2019
- (2019) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- PD-1/PD-L1 Inhibitors in Cervical Cancer
- (2019) Yuncong Liu et al. Frontiers in Pharmacology
- Going beyond the individual: how state-level characteristics relate to HPV vaccine rates in the United States
- (2019) Melissa Franco et al. BMC PUBLIC HEALTH
- Efficacy and Safety of Pembrolizumab in Previously Treated Advanced Cervical Cancer: Results From the Phase II KEYNOTE-158 Study
- (2019) Hyun Cheol Chung et al. JOURNAL OF CLINICAL ONCOLOGY
- The diversity of gut microbiome is associated with favorable responses to anti-PD-1 immunotherapy in Chinese non-small cell lung cancer patients
- (2019) Yueping Jin et al. Journal of Thoracic Oncology
- Deciphering the complex interplay between microbiota, HPV, inflammation and cancer through cervicovaginal metabolic profiling
- (2019) Zehra Esra Ilhan et al. EBioMedicine
- The vaginal microbiota, human papillomavirus and cervical dysplasia: a systematic review and network meta‐analysis
- (2019) J Norenhag et al. BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY
- Associations of Cervicovaginal Lactobacilli With High-Risk Human Papillomavirus Infection, Cervical Intraepithelial Neoplasia, and Cancer: A Systematic Review and Meta-Analysis
- (2019) Huiyan Wang et al. JOURNAL OF INFECTIOUS DISEASES
- Population-level impact and herd effects following the introduction of human papillomavirus vaccination programmes: updated systematic review and meta-analysis
- (2019) Mélanie Drolet et al. LANCET
- Features of the cervicovaginal microenvironment drive cancer biomarker signatures in patients across cervical carcinogenesis
- (2019) Paweł Łaniewski et al. Scientific Reports
- Gut microbiome affects the response to anti-PD-1 immunotherapy in patients with hepatocellular carcinoma
- (2019) Yi Zheng et al. Journal for ImmunoTherapy of Cancer
- CD40 Agonist Antibodies in Cancer Immunotherapy
- (2019) Robert H. Vonderheide Annual Review of Medicine
- Safety and Efficacy of Nivolumab Monotherapy in Recurrent or Metastatic Cervical, Vaginal, or Vulvar Carcinoma: Results From the Phase I/II CheckMate 358 Trial
- (2019) R. Wendel Naumann et al. JOURNAL OF CLINICAL ONCOLOGY
- Soluble immune checkpoint-related proteins as predictors of tumor recurrence, survival, and T cell phenotypes in clear cell renal cell carcinoma patients
- (2019) Qinchuan Wang et al. Journal for ImmunoTherapy of Cancer
- A Comprehensive Analysis of Key Immune Checkpoint Receptors on Tumor-Infiltrating T Cells From Multiple Types of Cancer
- (2019) Xi Li et al. Frontiers in Oncology
- The Immune Revolution: A Case for Priming, Not Checkpoint
- (2018) Robert H. Vonderheide CANCER CELL
- The commensal microbiome is associated with anti–PD-1 efficacy in metastatic melanoma patients
- (2018) Vyara Matson et al. SCIENCE
- The microbiome in cancer immunotherapy: Diagnostic tools and therapeutic strategies
- (2018) Laurence Zitvogel et al. SCIENCE
- Linking cervicovaginal immune signatures, HPV and microbiota composition in cervical carcinogenesis in non-Hispanic and Hispanic women
- (2018) Paweł Łaniewski et al. Scientific Reports
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Toll-like receptors: Important immune checkpoints in the regression of cervical intra-epithelial neoplasia 2
- (2018) Gordana Halec et al. INTERNATIONAL JOURNAL OF CANCER
- PD-L1 Expression Correlates With Tumor Infiltrating Lymphocytes And Response To Neoadjuvant Chemotherapy In Cervical Cancer
- (2018) Ying Meng et al. Journal of Cancer
- Vaginal dysbiosis, and the risk of human papillomavirus and cervical cancer: systematic review and meta-analysis
- (2018) Nele Brusselaers et al. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
- Vaginal Lactobacilli Induce Differentiation of Monocytic Precursors Toward Langerhans-like Cells: in Vitro Evidence
- (2018) Jie Song et al. Frontiers in Immunology
- The Protective Role of Bacteroides fragilis in a Murine Model of Colitis-Associated Colorectal Cancer
- (2018) Yun Kyung Lee et al. mSphere
- Soluble immune checkpoints in cancer: production, function and biological significance
- (2018) Daqian Gu et al. Journal for ImmunoTherapy of Cancer
- Safety and Efficacy of Pembrolizumab in Advanced, Programmed Death Ligand 1–Positive Cervical Cancer: Results From the Phase Ib KEYNOTE-028 Trial
- (2017) Jean-Sebastien Frenel et al. JOURNAL OF CLINICAL ONCOLOGY
- Bevacizumab for advanced cervical cancer: final overall survival and adverse event analysis of a randomised, controlled, open-label, phase 3 trial (Gynecologic Oncology Group 240)
- (2017) Krishnansu S Tewari et al. LANCET
- TLR2 and interleukin-10 are involved in Bacteroides fragilis-mediated prevention of DSS-induced colitis in gnotobiotic mice
- (2017) Yi-Chih Chang et al. PLoS One
- Gut microbiome modulates response to anti–PD-1 immunotherapy in melanoma patients
- (2017) V. Gopalakrishnan et al. SCIENCE
- Gut microbiome influences efficacy of PD-1–based immunotherapy against epithelial tumors
- (2017) Bertrand Routy et al. SCIENCE
- Emerging targets in cancer immunotherapy
- (2017) Samantha Burugu et al. SEMINARS IN CANCER BIOLOGY
- Natural History of HPV Infection across the Lifespan: Role of Viral Latency
- (2017) Patti Gravitt et al. Viruses-Basel
- Soluble PD-1 and PD-L1: predictive and prognostic significance in cancer
- (2017) Xinxin Zhu et al. Oncotarget
- The microbiome and the hallmarks of cancer
- (2017) Laura E. Fulbright et al. PLoS Pathogens
- Cancer immunotherapy: activating innate and adaptive immunity through CD40 agonists
- (2016) Gregory L. Beatty et al. Expert Review of Anticancer Therapy
- Gut environment-induced intraepithelial autoreactive CD4+ T cells suppress central nervous system autoimmunity via LAG-3
- (2016) Atsushi Kadowaki et al. Nature Communications
- Cervical Microbiome and Cytokine Profile at Various Stages of Cervical Cancer: A Pilot Study
- (2016) Astride Audirac-Chalifour et al. PLoS One
- ClustVis: a web tool for visualizing clustering of multivariate data using Principal Component Analysis and heatmap
- (2015) Tauno Metsalu et al. NUCLEIC ACIDS RESEARCH
- Commensal Bifidobacterium promotes antitumor immunity and facilitates anti-PD-L1 efficacy
- (2015) A. Sivan et al. SCIENCE
- Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota
- (2015) M. Vetizou et al. SCIENCE
- Cervical intraepithelial neoplasia disease progression is associated with increased vaginal microbiome diversity
- (2015) A. Mitra et al. Scientific Reports
- Expression of nucleic acid-sensing Toll-like receptors predicts HPV16 clearance associated with an E6-directed cell-mediated response
- (2014) Mark E. Scott et al. INTERNATIONAL JOURNAL OF CANCER
- CD40-Mediated Amplification of Local Immunity by Epithelial Cells Is Impaired by HPV
- (2014) Bart Tummers et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Lung microbiota promotes tolerance to allergens in neonates via PD-L1
- (2014) Eva S Gollwitzer et al. NATURE MEDICINE
- Tim-3 Expression in Cervical Cancer Promotes Tumor Metastasis
- (2013) Yang Cao et al. PLoS One
- Tim-3/galectin-9 signaling pathway mediates T-cell dysfunction and predicts poor prognosis in patients with hepatitis B virus-associated hepatocellular carcinoma
- (2012) Hang Li et al. HEPATOLOGY
- The Inhibitory Receptor PD-1 Regulates IgA Selection and Bacterial Composition in the Gut
- (2012) S. Kawamoto et al. SCIENCE
- CD40 is overexpressed by HPV16/18-E6 positive cervical carcinoma and correlated with clinical parameters and vascular density
- (2011) Qin Huang et al. Cancer Epidemiology
- Distinct Roles of CD28- and CD40 Ligand-Mediated Costimulation in the Development of Protective Immunity and Pathology during Chlamydia muridarum Urogenital Infection in Mice
- (2009) L. Chen et al. INFECTION AND IMMUNITY
- ORIGINAL ARTICLE: Quantification and Comparison of Toll-Like Receptor Expression and Responsiveness in Primary and Immortalized Human Female Lower Genital Tract Epithelia
- (2008) Melissa M. Herbst-Kralovetz et al. AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now